menu
    • menu

    Company profile for XenoTherapeutics

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    XenoTherapeutics Foundation is dedicated to the continued research and development of live-cellular xenotransplantation cells, tissues, and organs for therapeutic use. The Foundation focuses on product discovery and preclinical testing and works with our for-profit venture partner (XenoTherapeutics Corporation) to de-risk and optimize therapeutic candidates while decreasing the time to market. Our Foundation's goal to further ...
    XenoTherapeutics Foundation is dedicated to the continued research and development of live-cellular xenotransplantation cells, tissues, and organs for therapeutic use. The Foundation focuses on product discovery and preclinical testing and works with our for-profit venture partner (XenoTherapeutics Corporation) to de-risk and optimize therapeutic candidates while decreasing the time to market. Our Foundation's goal to further advance the science of xenotransplantation is best optimized through the establishment of two separate but affiliated organizations to support the rapid development of tangible therapeutic solutions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    XenoTherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    359 Newbury Street, 5th Floor Suite 526 Boston, MA 02115 ​
    Telephone
    Telephone
    617-939-7892 ​
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.xenotherapeutics.org/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/xenotherapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Repare Announces Completion of Acquisition by XenoTherapeutics
    Repare Announces Completion of Acquisition by XenoTherapeutics

    28 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260128195211/en/Repare-Announces-Completion-of-Acquisition-by-XenoTherapeutics-Inc.

    BUSINESSWIRE
    28 Jan 2026
    Share Share
    Repare Shareholders Approve Acquisition By Xenotherapeutics
    Repare Shareholders Approve Acquisition By Xenotherapeutics

    17 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260116246532/en/Repare-Shareholders-Approve-Acquisition-by-XenoTherapeutics-Inc.

    BUSINESSWIRE
    17 Jan 2026
    Share Share
    Repare Pharma Secures Backing From Major Shareholders
    Repare Pharma Secures Backing From Major Shareholders

    20 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251120902912/en/Repare-Therapeutics-Enters-into-Support-and-Voting-Agreements-with-Significant-Shareholders-for-Proposed-Transaction-with-XenoTherapeutics-Inc.

    BUSINESSWIRE
    20 Nov 2025
    Share Share
    Repare Nails Down Xenotherapeutics Buyout
    Repare Nails Down Xenotherapeutics Buyout

    17 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/repare-finds-fix-biotech-agrees-xenotherapeutics-buyout

    FIERCE BIOTECH
    17 Nov 2025
    Share Share
    ESSA Announces Completion Of Arrangement With Xenotherapeutics
    ESSA Announces Completion Of Arrangement With Xenotherapeutics

    09 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/essa-announces-completion-of-arrangement-with-xenotherapeutics-302579249.html

    PR NEWSWIRE
    09 Oct 2025
    Share Share
    ESSA Securityholders Approve Acquisition By Xenotherapeutics
    ESSA Securityholders Approve Acquisition By Xenotherapeutics

    06 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/essa-securityholders-approve-acquisition-by-xenotherapeutics-302576261.html

    PR NEWSWIRE
    06 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search